1. A mimic of lung adenocarcinoma: a case report of histological conversion of metastatic thyroid papillary carcinoma. Issue 6 (28th January 2022) Authors: Takemura, Chihiro; Kashima, Jumpei; Hashimoto, Taiki; Ichikawa, Hitoshi; Honma, Yoshitaka; Goto, Yasushi; Watanabe, Shun‐Ichi; Yatabe, Yasushi Journal: Histopathology Issue: Volume 80:Issue 6(2022) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study). (19th May 2020) Authors: Nomura, Shogo; Goto, Yasushi; Mizutani, Tomonori; Kataoka, Tomoko; Kawai, Shoko; Okuma, Yusuke; Murakami, Haruyasu; Tanaka, Kentaro; Ohe, Yuichiro Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 7(2020) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Absence of toxic epidermal necrolysis recurrence with pembrolizumab re‐challenge in a patient with a positive lymphocyte transformation test. Issue 12 (20th August 2020) Authors: Kawada, Moeka; Nobeyama, Yoshimasa; Goto, Yasushi; Nakama, Kenta; Yamazaki, Naoya; Asahina, Akihiko Journal: Journal of dermatology Issue: Volume 47:Issue 12(2020) Page Start: e424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody. Issue 12 (27th October 2020) Authors: Murakami, Shuji; Shibaki, Ryota; Matsumoto, Yuji; Yoshida, Tatsuya; Goto, Yasushi; Kanda, Shintaro; Horinouchi, Hidehito; Fujiwara, Yutaka; Yamamoto, Noboru; Ohe, Yuichiro Journal: Thoracic cancer Issue: Volume 11:Issue 12(2020) Page Start: 3585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer. (February 2022) Authors: Shirasawa, Masayuki; Yoshida, Tatsuya; Imabayashi, Tatsuya; Okuma, Kae; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Tsuchida, Takaaki; Yamamoto, Noboru; Nakayama, Yuko; Watanabe, Shun-ichi; Motoi, Noriko; Ohe, Yuichiro Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer. (October 2018) Authors: Sekine, Katsutoshi; Kanda, Shintaro; Goto, Yasushi; Horinouchi, Hidehito; Fujiwara, Yutaka; Yamamoto, Noboru; Motoi, Noriko; Ohe, Yuichiro Journal: Lung cancer Issue: Volume 124(2018) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression. (3rd July 2018) Authors: Hosomi, Yukio; Tanai, Chiharu; Yoh, Kiyotaka; Goto, Yasushi; Sakai, Hiroshi; Kato, Terufumi; Kaburagi, Takayuki; Nishio, Makoto; Kim, Young Hak; Inoue, Akira; Hasegawa, Yoshinori; Isobe, Hiroshi; Tomizawa, Yoshio; Mori, Yoshiaki; Minato, Koichi; Yamada, Kazuhiko; Ohashi, Yasuo; Kunitoh, Hideo Journal: Expert opinion on pharmacotherapy Issue: Volume 19:Number 10(2018) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (8th June 2021) Authors: Takeyasu, Yuki; Yoshida, Tatsuya; Motoi, Noriko; Teishikata, Takashi; Tanaka, Midori; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Kakishima, Hiroki; Tsuchida, Takaaki; Yamamoto, Noboru; Ohe, Yuichiro; Yatabe, Yasushi Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 7(2021) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Corrigendum to: Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan. (17th February 2020) Authors: Yoh, Kiyotaka; Takamochi, Kazuya; Shukuya, Takehito; Hishida, Tomoyuki; Tsuboi, Masahiro; Sakurai, Hiroyuki; Goto, Yasushi; Yoshida, Koichi; Ohde, Yasuhisa; Okumura, Sakae; Ohashi, Yasuo; Kunitoh, Hideo Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 4(2020) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single‐cell level. Issue 5 (2nd April 2021) Authors: Nakamura, Ikuko Takeda; Ikegami, Masachika; Hasegawa, Nobuhiko; Hayashi, Takuo; Ueno, Toshihide; Kawazu, Masahito; Yagishita, Shigehiro; Goto, Yasushi; Shinno, Yuki; Kojima, Yuki; Takamochi, Kazuya; Takahashi, Fumiyuki; Takahashi, Kazuhisa; Mano, Hiroyuki; Kohsaka, Shinji Journal: Cancer science Issue: Volume 112:Issue 5(2021) Page Start: 2006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗